AT4 receptor binding characteristics: d-Amino acid- and glycine-substituted peptides

Baker, 1990, Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells, Am. J. Physiol., 259, H610 Braszko, 1988, Angiotensin II (3–8) hexapeptide affects motor activity, performance of passive avoidance and conditioned avoidance response in rats, Neuroscience, 27, 777, 10.1016/0306-4522(88)90182-0 Braszko, 1991, The 3–7 fragment of angiotensin II is probably responsible for its psychoactive properties, Brain Res., 542, 49, 10.1016/0006-8993(91)90996-9 Coleman, 1992, Changes in renal blood flow due to infusions of angiotensin II (3–8) [AIV] in normotensive rats, FASEB J., 6, A981 Coleman, 1993, Changes in renal blood flow due to intra-arterial infusions of angiotensin II (3–8) [AIV] and AIV analogs, FASEB J., 7, A437 Glossman, 1974, Properties of angiotensin II receptors in the bovine and rat adrenal cortex, J. Biol. Chem., 249, 825, 10.1016/S0021-9258(19)43003-2 Haberl, 1991, Angiotensin degradation products mediate endothelium-dependent dilation of rabbit brain arterioles, Circ. Res., 68, 1621, 10.1161/01.RES.68.6.1621 Hanesworth, J. M.; Sardinia, M. F.; Krebs, L. T.; Hall, K. L.; Harding, J. W. Elucidation of a specific binding site for angiotensin II (3–8), angiotensin IV, in mammalian heart membranes. J. Pharmacol. Exp. Ther. (in press). Harding, 1992, Identification of an AII(3–8) [AIV] binding site in guinea pig hippocampus, Brain Res., 583, 340, 10.1016/S0006-8993(10)80047-2 Jarvis, 1992, The angiotensin hexapeptide 3–8 fragment potently inhibits [125I] angiotensin II binding to non-AT1 or -AT2 recognition sites in bovine adrenal cortex, Eur. J. Pharmacol., 219, 319, 10.1016/0014-2999(92)90312-R Kaiser, 1970, Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides, Anal. Biochem., 34, 595, 10.1016/0003-2697(70)90146-6 Lowry, 1951, Protein measurement with the folin phenol reagent, J. Biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6 Munson, 1980, LIGAND: A versatile computerized approach to characterization of ligand binding systems, Anal. Biochem., 107, 220, 10.1016/0003-2697(80)90515-1 Pendelton, 1989, Studies defining minimal receptor domains for angiotensin II, J. Pharmacol. Exp. Ther., 250, 31 Swanson, 1992, Discovery of a distinct binding site for angiotensin II (3–8), a putative angiotensin IV receptor, Regul. Pept., 40, 400, 10.1016/0167-0115(92)90527-2 Swanson, 1992, Solubilization of a new angiotensin receptor subtype from bovine adrenals, FASEB J., 6, A1576 Timmermans, 1991, Nonpeptide angiotensin II receptor antagonists, Trends Pharmacol. Sci., 12, 55, 10.1016/0165-6147(91)90498-H Whitebread, 1989, Preliminary biochemical characterization of two angiotensin II receptor subtypes, Biochem. Biophys. Res. Commun., 163, 284, 10.1016/0006-291X(89)92133-5 Wright, J. W.; Miller-Wing, A. V.; Shaffer, M. J.; et al. Angiotensin II (3–8) [AIV] hippocampal binding: Potential role in the facilitation of memory. Brain Res. Bull. (in press). Wright, 1990, Intracerebroventricularly infused [d-Arg1] angiotensin III, is superior to [d-Asp1] angiotensin II, as a pressor agent in rats, Brain Res., 514, 5, 10.1016/0006-8993(90)90428-E